Director Mika Grasso files initial Form 3 at BioRestorative (BRTX)

Rhea-AI Filing Summary

BioRestorative Therapies, Inc. director Mika Grasso has filed an initial Form 3, which is the required statement of beneficial ownership for new insiders. This filing lists Grasso as a director and does not report any buy, sell, or other insider transactions.

Key Terms

Form 3, reporting person, ten percent owner

3 terms

Form 3 regulatory

"has filed an initial Form 3, which is the required statement"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons": [ { "name": "Grasso Mika""

ten percent owner regulatory

""is_ten_percent_owner": 0"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/18/2026 - 04:33 PM Accepted by SEC EDGAR 06/18/2026 - 04:32 PM Learn about SEC filing dates

FAQ

What does the BioRestorative Therapies (BRTX) Form 3 for Mika Grasso show?

The Form 3 identifies Mika Grasso as a director of BioRestorative Therapies. It serves as an initial statement of beneficial ownership for this insider and does not list any insider transactions or derivative positions at the time of filing.

Did Mika Grasso buy or sell BRTX shares in this Form 3 filing?

No insider trades are reported in this Form 3. The transaction summary shows zero buy, sell, acquire, dispose, or other transaction counts, indicating the filing is purely an initial ownership statement rather than a record of trading activity.

Does the BRTX Form 3 for Mika Grasso indicate ten percent ownership?

The Form 3 flags Mika Grasso as a director but not as a ten percent owner. The ten percent owner indicator is set to zero, meaning the filer is treated as an insider by role on the board rather than based on owning ten percent or more of the company.

Are any derivative securities reported for Mika Grasso in the BRTX Form 3?

No derivative positions are reported in this Form 3. The derivative summary section is empty and the derivative transaction count is zero, indicating there are no listed options, warrants, or other derivative securities for this reporting person in the filing data provided.

What is the purpose of this BioRestorative Therapies (BRTX) Form 3 filing?

This Form 3 serves as an initial disclosure of insider status for director Mika Grasso at BioRestorative Therapies. It fulfills regulatory requirements for insiders to file a beneficial ownership statement when they first become subject to Section 16 reporting obligations.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Grasso Mika

(Last) (First) (Middle)

40 MARCUS DRIVE

C/O BIORESTORATIVE THERAPIES, INC.

(Street)

MELVILLE NEW YORK 11747

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/10/2026

3. Issuer Name and Ticker or Trading Symbol
BioRestorative Therapies, Inc. [ BRTX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Mika Grasso	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)